Gary Bellinger

3.3k citations

13 papers · 1.9k indexed · 2 hit papers · h-index 11

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Mitochondrial Function and Pathology
- Epigenetics and DNA Methylation
- Redox biology and oxidative stress
- RNA modifications and cancer

Papers in ⓘ

Cancer Research 7
- Cancer, Hypoxia, and Metabolism 4
- Breast Cancer Treatment Studies 2
Otorhinolaryngology 2

Co-authors: Lewis C. Cantley (7 shared papers)John M. Asara (5 shared papers)George Poulogiannis (4 shared papers)Atsuo T. Sasaki (3 shared papers)Dimitrios Anastasiou (2 shared papers)Matthew G. Vander Heiden (3 shared papers)Jian‐kang Jiang (2 shared papers)Douglas S. Auld (2 shared papers)
Journals: Proceedings of the National Academy of Sciences (3 papers)Clinical Cancer Research (1 paper)Oncogenesis (1 paper)Science (1 paper)Oncotarget (1 paper)
Partner nations: United States Canada Switzerland

In The Last Decade

Gary Bellinger

13 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1 2013 · 517 citations

Peers

Countries citing papers authored by Gary Bellinger

Since Specialization

Citations

This map shows the geographic impact of Gary Bellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bellinger more than expected).

Fields of papers citing papers by Gary Bellinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bellinger. The network helps show where Gary Bellinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Bellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Bellinger Line = papers co-authored together Gary Bellinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses Science ·Dimitrios Anastasiou, George Poulogiannis, John M. Asara, Matthew B. Boxer, Jian‐kang Jiang, Min Shen, Gary Bellinger, Atsuo T. Sasaki, Jason W. Locasale, Douglas S. Auld, Craig J. Thomas, Matthew G. Vander Heiden, Lewis C. Cantley Hit paper breakdown →	2011	941
2	AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1 Molecular Cell ·Ning Wu, Bin Zheng, Adam J. Shaywitz, Yossi Dagon, Christine Tower, Gary Bellinger, Che-Hung Shen, Jennifer Wen, John M. Asara, Timothy E. McGraw, Barbara B. Kahn, Lewis C. Cantley Hit paper breakdown →	2013	517
3	Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors Cell ·Brooke M. Emerling, Jonathan Hurov, George Poulogiannis, Kazumi S. Tsukazawa, Rayman Choo-Wing, Gerburg M. Wulf, Eric L. Bell, Hyeseok Shim, Katja Lamia, Lucia E. Rameh, Gary Bellinger, Atsuo T. Sasaki, John M. Asara, Xin Yuan, Andrea J. Bullock, Gina M. DeNicola, Jiaxi Song, Victoria E. Brown, Sabina Signoretti, Lewis C. Cantley	2013	144
4	Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion Proceedings of the National Academy of Sciences ·Ashish Juvekar, Hai Hu, Sina Yadegarynia, Costas A. Lyssiotis, Soumya Ullas, Evan C. Lien, Gary Bellinger, Jaekyoung Son, Rosanna Hok, Pankaj Seth, Michele B. Daly, Baek Kim, Ralph Scully, John M. Asara, Lewis C. Cantley, Gerburg M. Wulf	2016	71
5	ErbB2 is required for ductal morphogenesis of the mammary gland Proceedings of the National Academy of Sciences ·Amy Jackson-Fisher, Gary Bellinger, Rajani Ramabhadran, Jacqueline K. Morris, Kuo‐Fen Lee, David F. Stern	2004	64
6	Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients Proceedings of the National Academy of Sciences ·Brooke M. Emerling, Cyril H. Benes, George Poulogiannis, Eric L. Bell, Kevin D. Courtney, Hui Liu, Rayman Choo-Wing, Gary Bellinger, Kazumi S. Tsukazawa, Victoria E. Brown, Sabina Signoretti, Stephen P. Soltoff, Lewis C. Cantley	2013	49
7	Demethylation Therapy as a Targeted Treatment for Human Papillomavirus–Associated Head and Neck Cancer Clinical Cancer Research ·Asel Biktasova, Michael Hajek, Andrew K. Sewell, Cyril Gary, Gary Bellinger, Hari A. Deshpande, Aarti Bhatia, Barbara Burtness, Benjamin L. Judson, Saral Mehra, Wendell G. Yarbrough, Natalia Issaeva	2017	46
8	ErbB3 is required for ductal morphogenesis in the mouse mammary gland Breast Cancer Research ·Amy Jackson-Fisher, Gary Bellinger, Jerrica L. Breindel, F. A. Tavassoli, Carmen J. Booth, James Duong, David F. Stern	2008	44
9	Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4 Oncogene ·Amy Jackson-Fisher, Gary Bellinger, Elaine Shum, Janna K. Duong, Archibald S. Perkins, Martin Gassmann, William J. Muller, K. C. Kent Lloyd, David F. Stern	2006	19
10	Selective antitumor activity of roscovitine in head and neck cancer Oncotarget ·Cyril Gary, Michael Hajek, Asel Biktasova, Gary Bellinger, Wendell G. Yarbrough, Natalia Issaeva	2016	14
11	Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner Oncogenesis ·J. Jacob Wamsley, C. Gary, Asel Biktasova, Michael Hajek, Gary Bellinger, Renu K. Virk, Natalia Issaeva, Wendell G. Yarbrough	2017	12
12	Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism Cancer Research ·Sarah‐Maria Fendt, Eric L. Bell, Mark A. Keibler, Shawn M. Davidson, Grégory J. Wirth, Brian P. Fiske, Jared R. Mayers, Matthias Schwab, Gary Bellinger, Alfred Csibi, Akash Patnaik, Marie Jose Blouin, Lewis C. Cantley, Leonard Guarente, John Blenis, Michaël Pollak, Aria F. Olumi, Matthew G. Vander Heiden, Gregory Stephanopoulos	2013	7
13	Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses DSpace@MIT (Massachusetts Institute of Technology) ·Matthew G. Vander Heiden, Dimitrios Anastasiou, George Poulogiannis, John M. Asara, Matthew B. Boxer, Jian‐kang Jiang, Min Shen, Gary Bellinger, Atsuo T. Sasaki, Jason W. Locasale, Douglas S. Auld, Craig J. Thomas, Lewis C. Cantley	2011	2

About Gary Bellinger

Gary Bellinger is a scholar working on Cancer Research, Otorhinolaryngology, Oncology, Molecular Biology and Cell Biology, having authored 13 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers), HER2/EGFR in Cancer Research (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Breast Cancer Treatment Studies (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cancer Cells and Metastasis (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (749 citations), Molecular Biology (1.4k citations), Biochemistry (118 citations), Oncology (360 citations) and Cell Biology (201 citations). Gary Bellinger has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Lewis C. Cantley, John M. Asara, George Poulogiannis, Atsuo T. Sasaki, Dimitrios Anastasiou, Matthew G. Vander Heiden, Jian‐kang Jiang, Douglas S. Auld, Craig J. Thomas and Min Shen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research, Oncogenesis, Science and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact